Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round

  • Feed Type
  • Date
    3/6/2012
  • Company Name
    Aragon Pharmaceuticals
  • Mailing Address
    12780 El Camino Real San Diego, CA 92130
  • Company Description
    Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
  • Website
    http://www.aragonpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $42,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    This $42 million round of financing puts Aragon on strong footing to execute on its promising pipeline in prostate cancer and breast cancer.
  • M&A Terms
  • Venture Investor
    Topspin Partners
  • Venture Investor
    Aisling Capital
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    The Column Group

By posting a comment, you agree to our terms and conditions.